Nikki Cheng

Nikki Cheng is a Professor at the University of Kansas Medical Center since July 2008, focusing on biomedical research in the department of Pathology and Laboratory Medicine, particularly regarding inflammation and chemo lines in breast cancer. Additionally, Nikki Cheng co-founded and serves as Chief Scientific Officer at Fennik Life Sciences, LLC since February 2016. Previous academic roles include positions at Vanderbilt University, where Nikki Cheng worked as a research assistant professor and contributed to significant projects on TGF-beta signaling in mammary tumor progression. Academic qualifications comprise a PhD in cancer biology from Vanderbilt University and a Bachelor of Science in Biochemistry from Beloit College. Career achievements include multiple publications and the NIH postdoctoral fellowship award, along with extensive research experience from various institutions.